Thermo Fisher Scientific expands its SARS-CoV-2 testing portfolio in India with a point-of-care testing platform

The Accula System is an innovative platform that will accelerate the availability of reliable and accurate advanced molecular diagnostics at the point of care.

Mumbai (Maharashtra) [India], June 15: Thermo Fisher Scientific today announced the introduction of the new and innovative Accula SARS-CoV-2 Test that delivers gold-standard reverse transcription-polymerase chain reaction (RT-PCR) detection of SARS-CoV-2 in a point-of-care format.

The Accula SARS-CoV-2 Test has received Emergency Use Authorization (EUA) from the United States (U.S.) Food and Drug Administration (FDA) for the detection of SARS-CoV-2 in Clinical Laboratory Improvement Amendments (CLIA)–waived environments.

“Since the start of the pandemic, Thermo Fisher has acted quickly to provide support to the scientists and healthcare professionals at the frontlines of combating COVID-19,” said Amit Chopra, Managing Director, India, and South Asia, Thermo Fisher Scientific. “Thermo Fisher’s new testing platform combines the accuracy of RT-PCR with the simplicity, convenience, and procedural familiarity of traditional rapid immunoassays. The Accula SARS-CoV-2 Test is a natural extension to our existing offerings and will significantly help to meet the continuing demands for rapid and reliable COVID-19 testing in India.”

RT-PCR testing is streamlined from start to finish using a fully integrated, single-use microfluidic test cassette and the reusable, palm-sized Accula Dock. The test uses nasal swab samples and provides reliable, qualitative results in approximately 30 minutes. The Accula SARS-CoV-2 Test is enabled by proprietary PCR technology that allows for reduced absolute temperatures and reduced temperature differentials—resulting in rapid exponential amplification while reducing overall thermocycling times.

“The rapid Accula point-of-care test will open new avenues of personal and public testing without compromising on accuracy,” added Amit. “The introduction of the test in India is a demonstration of the impact our solutions have on human health during the pandemic, and far beyond.”

In January 2021, Thermo Fisher acquired Mesa Biotech Inc., which developed the Accula SARS-CoV-2 Test to provide accurate and faster results at the point of care.

For more information, please visit www.thermofisher.com

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner, and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies, or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience, and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon.

Related Posts

Continued vigilance is essential to protect India’s polio-free status

Dr Sachin Shah Pune (Maharashtra) [India], November 17: India’s polio-free status is a public-health achievement built over years through vaccination and surveillance. Its continuation depends on keeping immunisation coverage high…

Apollo Health strengthens its expansion in North India with New Clinic and National Reference Laboratory in Gurugram

Apollo Clinic and Apollo Diagnostic’ National Reference Laboratory, have joined forces together to establish a comprehensive healthcare facility in sector 52, Gurugram, strengthening its healthcare expansion in Northern India. Inaugurated…

You Missed

Neetu Yoshi Reports 4.0% YoY Growth in Net Profit in H1 FY27 to Rs 12.00 Crore; Total Income Stands at Rs 59.38 Crore

Neetu Yoshi Reports 4.0% YoY Growth in Net Profit in H1 FY27 to Rs 12.00 Crore; Total Income Stands at Rs 59.38 Crore

Global Schools Group Opens Applications for Fully Funded Global Citizen Scholarship 2027

Global Schools Group Opens Applications for Fully Funded Global Citizen Scholarship 2027

India’s DeepTech Capital Needs People Who Can Put It to Work

India’s DeepTech Capital Needs People Who Can Put It to Work

Aahwahan Foundation Begins Cyclone Relief Drive in Odisha Distributes 30,000 Grocery & Relief Kits Across Ganjam, Malkangiri and Koraput

Aahwahan Foundation Begins Cyclone Relief Drive in Odisha Distributes 30,000 Grocery & Relief Kits Across Ganjam, Malkangiri and Koraput

Bench Mark Infotech Services Limited Reports H1 FY27 Results

Bench Mark Infotech Services Limited Reports H1 FY27 Results

Raise Money Ventures Lights Up Noida’s Startup Ecosystem with a Festive Diwali Networking Celebration

Raise Money Ventures Lights Up Noida’s Startup Ecosystem with a Festive Diwali Networking Celebration